Gordon Zong is trying to teach Chinese universities and research institutes, how to make effective technology transfer and licensing of IP, but he's trying to do it in an environment with weak property rights and the lack of infrastructure support. As Managing Director of the Office of Technology Transfer in Shanghai Institute for Biological Sciences, he is working with researchers at the forefront of biology and biotechnology, but he is faced with insurmountable obstacles for technologies within the commercial domestic Chinese companies, so it has turned global multinational pharmaceutical companies at the moment. The purpose of the case to help current and future managers in global multinational corporations that are responsible for the R & D strategy to understand some of China's intellectual property protection so that they can build effective participation strategy for their organizations. Understanding misaligned incentives that lead to unwanted problems patents and patent rights, as well as the direction of change is vital because, as the Chinese system is developing rapidly, the impact of these changes will have important commercial implications. "Hide
by Willy Shih, Sen Chai, Stone Bliznashki, Courtney Hyland Source: Harvard Business School 28 pages. Publication Date: March 24, 2011. Prod. #: 611057-PDF-ENG
